You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Award Disclosure
Homcy Charles J · SEC Form 4 · Filed Jun 24, 2026
Award
Calculated transaction value
$0
Homcy Charles J Director
BBIO
BridgeBio Pharma
BBIO
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
BBIO daily price context
Close on/before transaction
$68.92
Jun 22, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 5,277 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001470831-26-000633
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Award | Jun 22, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO Current | Award | Jun 22, 2026 | $0 |